LifeVantage (NASDAQ:LFVN) Shares Pass Above Two Hundred Day Moving Average of $6.64

LifeVantage Co. (NASDAQ:LFVN)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.64 and traded as high as $8.57. LifeVantage shares last traded at $8.35, with a volume of 77,470 shares traded.

LifeVantage Price Performance

The stock has a market capitalization of $106.05 million, a P/E ratio of 29.82 and a beta of 0.81. The stock has a 50 day moving average price of $6.97 and a 200-day moving average price of $6.64.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.21 earnings per share (EPS) for the quarter. LifeVantage had a return on equity of 27.02% and a net margin of 1.75%. The business had revenue of $48.25 million for the quarter.

Institutional Investors Weigh In On LifeVantage

Institutional investors have recently added to or reduced their stakes in the company. Empowered Funds LLC raised its stake in shares of LifeVantage by 8.1% during the first quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock valued at $461,000 after acquiring an additional 5,742 shares during the last quarter. Acadian Asset Management LLC increased its holdings in LifeVantage by 2.8% during the 1st quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after purchasing an additional 6,121 shares during the period. Hillsdale Investment Management Inc. bought a new position in LifeVantage during the 1st quarter valued at approximately $76,000. Hantz Financial Services Inc. bought a new position in LifeVantage during the 2nd quarter valued at approximately $91,000. Finally, Vanguard Group Inc. lifted its holdings in LifeVantage by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock worth $2,874,000 after buying an additional 12,809 shares during the period. Hedge funds and other institutional investors own 35.32% of the company’s stock.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.